July 19, 2023

Removing dosing guidance from a guideline summary takes a valuable tool from prescribers, says Dr. Mark Sullivan and pain-medicine colleagues.

June 27, 2023

The FDA should amend its buprenorphine dose limit, which is outdated, according to a recent literature review. 

June 26, 2023

Seattle investigators will coordinate the American Heart Association's $20 million initiative to improve care for millions.

picture of a hand holding a Narcan nasal spray dispenser
March 29, 2023

Narcan, a brand-name prescription nasal spray effective at reversing opioid overdoses, can be sold over the counter, the Food and Drug Administration decided today. Narcan’s active agent is naloxone.  

May 27, 2022

Researchers will explore the ability of Black and Latinx patients to get the less-stigmatized treatment drug, buprenorphine.

March 8, 2022

In Washington state, 42% of respondents said they had used the dangerous opioid in the previous 3 months.

New pain-treatment guidelines proposed by the Centers for Disease Control and Prevention include eliminating recommended dose limits for some patients who suffer from chronic pain. The guidelines also encourage non-opioid treatments as a first option, when possible.
February 23, 2022

New pain-treatment guidelines proposed by the Centers for Disease Control and Pre

December 8, 2021

Overdose death rates with the drug are similar for those under and over 30 – a break from patterns involving heroin and prescribed opioids. 

November 22, 2021

Researchers develop a prototype device that can recognize respiration patterns and administer naloxone, a potential antidote.

November 17, 2021

Injury-prevention and addiction specialists at UW Medicine collaborate to produce a web tool for teens and parents. 


Subscribe to opioids